The Delhi High Court will today hear the pleas of 30 pharma companies challenging the ban imposed by the Health Ministry on various fixed dose combinations (FDCs). Last week on March 21, the Delhi High Court has adjourned the hearing till today, March 28.
Currently, the pharma stocks are trading lower at BSE ahead of the hearing.
The Health Ministry, via a gazette notification on March 10 banned 344 fixed dose combinations (FDCs) drugs.
The BSE Healthcare index is currently trading at 15,289.49 points, down by 159.78 points or 1.03%. The index opened higher at 15,488.95 points as against its previous close of 15,449.27 points. It hit a high and a low of 15,492.89 points and 15,279.85 points respectively.
The sectoral breadth is negative with 45 stocks declined, 17 stocks advanced and one stock unchanged.
GlaxoSmithKilne Pharma is currently trading at Rs. 3,644 (-1.08%), Pfizer at Rs. 1,696.70 (-Rs. 0.92%), Wockhardt at Rs. 943.60 (-1.37%), Piramal Enterprises at Rs. 97.20 (up 0.27%), Abbott India at Rs. 4,730.45 (-0.57%), Coral Lab at Rs. 460 (-1.35%), FDC Ltd at Rs. 177.50 (-1.42%) and Alkem Lab at Rs. 1,365.25 (0.63%).
No comments:
Post a Comment